Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rose bengal lactone is a synthetic organic small molecule classified as a xanthene dye and a derivative of fluorescein. It features multiple halogen atoms (chlorine and iodine) attached to a xanthene backbone with a distinctive lactone ring that influences its solubility and reactivity. It acts primarily as a photosensitizer generating reactive oxygen species such as singlet oxygen upon light activation, which induces cytotoxic effects useful in photodynamic therapy. Additionally, it inhibits motor proteins like kinesin by binding to specific sites disrupting intracellular transport processes. The compound has applications as a biological stain and colorant in inks, cosmetics, foods, medicine (diagnostic aid), and research fields including photodynamic therapy due to its unique photophysical properties. Its molecular formula is C20H4Cl4I4O5 with an average molecular weight of approximately 973.66 g/mol.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on rose bengal lactone.